 |
Click here for
NJ Preventive Cardiology practice brochure
|
Mentoring Program |
|
The Million Hearts
Initiative
For Physicians:
Practical Tips for
Clinicians
For Communities:
Heart2Heart Talk
For Employers and Employees:
You and Health Reform
|
|
|
 |
| | A large volume of compelling scientific data from many clinical trials have proven and effectiveness and safety of cholesterol treatment in patients with and without heart disease, and patients with high, normal and even low levels.
In patients with heart disease, cholesterol treatment (simvastatin) reduced stroke by 30%, fatal heart attack by 42%, heart bypass by 37% compared to those that took placebo.
In patients without heart disease, cholesterol treatment (lovastatin) reduced fatal heart attack by 40% and heart bypass by 33% compared to placebo.
| |
|
Emil M. deGoma, MD, FACC
Medical Director,
UPenn Preventive
Cardiovascular Program
|
Health Premium Discount |
|
Lower your risk for heart attack and stroke
using evidence-based therapies and become
eligible for a substantial premium discount by
2014.
|
|
|
|
|
|
Health Reform 2010 |
|
Prevention and Wellness Summary Provisions
|
|
|
|
|
|
Relay Health |
|
Contact Office for Non-Urgent Matters
|
|
|
|
|
We Support
Million Hearts Initiative
497,470 Preventable CHD Deaths
Annually with
Evidence-based Medical Therapy
JAMA: 38% of Nonacute
Stents Called into Question
Optimal Medical Therapy Still Underused in
CHD
Legacy Effects
of Statin Therapy - Reduction in
All-Cause Mortality
SG2 Expert Talks About Resetting
Priorities in Cardiology
AHA: Get With The Guidelines - Not Much
Improvement
AIM-HIGH Trial -
Take Home
Message
|
